These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18722605)

  • 41. [Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].
    Knebel B; Janssen OE; Hahn S; Nitzgen U; Jacob S; Haas J; Mack S; Müller-Wieland D; Kotzka J
    Dtsch Med Wochenschr; 2009 May; 134(20):1040-6. PubMed ID: 19421925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
    Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polycystic ovarian syndrome in the adolescent-the focus is new and exciting.
    Sanfilippo JS
    J Pediatr Adolesc Gynecol; 2008 Jun; 21(3):113-4. PubMed ID: 18549961
    [No Abstract]   [Full Text] [Related]  

  • 44. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH; Khalid R; Naru T; Rizvi J
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
    Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
    J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome.
    Kebapcilar L; Taner CE; Kebapcilar AG; Sari I
    Arch Gynecol Obstet; 2009 Aug; 280(2):187-93. PubMed ID: 19107500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic ovarian syndrome: what it is and why registered dietitians need to know.
    Stein K
    J Am Diet Assoc; 2006 Nov; 106(11):1738-41. PubMed ID: 17081819
    [No Abstract]   [Full Text] [Related]  

  • 49. Polycystic ovary syndrome and its relevance to women from south Asia.
    Wijeyaratne CN; Balen AH; Belchetz PE
    Ceylon Med J; 2002 Mar; 47(1):22-6. PubMed ID: 12001601
    [No Abstract]   [Full Text] [Related]  

  • 50. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
    Abdel Fattah NS; Darwish YW
    Br J Dermatol; 2009 May; 160(5):1011-5. PubMed ID: 19298279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial aspects of women with polycystic ovary syndrome from south India.
    Sundararaman PG; Shweta ; Sridhar GR
    J Assoc Physicians India; 2008 Dec; 56():945-8. PubMed ID: 19322973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycystic ovarian syndrome in adolescents.
    Creatsas G; Deligeoroglou E
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):420-6. PubMed ID: 17885456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut hormones, obesity, polycystic ovarian syndrome, malignancy, and lipodystrophy syndromes.
    Bloomgarden ZT
    Diabetes Care; 2007 Jul; 30(7):1934-9. PubMed ID: 17596508
    [No Abstract]   [Full Text] [Related]  

  • 56. Diabetes mellitus type 2 through oncology lens.
    Alfarouk KO; Bashir AH
    Med Hypotheses; 2011 May; 76(5):761-2. PubMed ID: 21316865
    [No Abstract]   [Full Text] [Related]  

  • 57. Insulin resistance, hypercortisolism, polycystic ovarian syndrome, and depression--nonrandom associations?
    Castillo-Quan JI
    Fertil Steril; 2008 Apr; 89(4):1029-30; author reply 1030. PubMed ID: 18325512
    [No Abstract]   [Full Text] [Related]  

  • 58. Association of vitamin D3 deficiency with clinical and biochemical parameters in Indian women with polycystic ovary syndrome.
    Bhattacharya SM; Jha A
    Int J Gynaecol Obstet; 2013 Oct; 123(1):74-5. PubMed ID: 23886450
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of android fat distribution on thrombin-activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome.
    Mendonça-Louzeiro MRMF; Andrade KC; Yela DA; Benetti-Pinto CL
    Int J Gynaecol Obstet; 2018 Oct; 143(1):108-109. PubMed ID: 29931680
    [No Abstract]   [Full Text] [Related]  

  • 60. The 4th International Congress on the Insulin Resistance Syndrome.
    Styne DM
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):358-61. PubMed ID: 17643084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.